Canada Markets close in 2 hrs 24 mins

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.10-0.87 (-9.70%)
As of 01:31PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close8.97
Bid8.18 x 1000
Ask8.20 x 1000
Day's Range8.10 - 8.99
52 Week Range6.54 - 49.51
Avg. Volume304,526
Market Cap338.023M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.68
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est70.90
  • GlobeNewswire

    COMPASS Pathways to participate in upcoming Citi’s Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference

    LONDON, May 12, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in two upcoming events as follows: Citi’s Biopharma Virtual Co-Panel Day: panel “Mood Disorders/Mental Health Panel” at 11:00 am ET on 18 May 2022HC Wainwright Global Investments Conference: presentation at 9:00 am ET on 24 May 2022 A live audio webcast of

  • Motley Fool

    COMPASS Pathways plc (CMPS) Q1 2022 Earnings Call Transcript

    Good morning, and welcome to COMPASS Pathways first quarter '22 earnings call. Again, my name is Stephen Schultz, senior vice president of investor relations at COMPASS Pathways. Today, I'm joined by George Goldsmith, chairman and chief executive officer; Dr.

  • GlobeNewswire

    COMPASS Pathways plc announces first quarter 2022 financial results and business highlights

    LONDON, May 10, 2022 (GLOBE NEWSWIRE) -- Highlights: End of phase II meeting held with FDAAward of Innovation Passport as part of the UK MHRA Innovative Licensing and Access Pathway ILAPFinalising phase III in TRD program design to be ready for second half of 2022Pioneering collaboration with King’s College London and South London and Maudsley NHS Foundation Trust, to create The Centre for Mental Health Research and Innovation in the UKCash position at 31 March 2022 of $243.7 millionConference c